GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,450 | +1.7% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,426 | +14160.0% | 40 | -85.9% | 0.00% | -80.0% |
| Q1 2023 | $10 | +11.1% | 283 | +16.5% | 0.01% | +25.0% |
| Q4 2022 | $9 | -99.9% | 243 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $7,000 | -53.3% | 243 | -69.8% | 0.01% | 0.0% |
| Q2 2022 | $15,000 | -16.7% | 804 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $18,000 | -10.0% | 804 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $20,000 | -16.7% | 804 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $24,000 | +100.0% | 804 | +164.5% | 0.01% | +83.3% |
| Q2 2021 | $12,000 | +9.1% | 304 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $11,000 | 0.0% | 304 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $11,000 | -69.4% | 300 | -68.4% | 0.01% | -75.0% |
| Q3 2020 | $36,000 | +33.3% | 950 | +46.2% | 0.02% | +17.6% |
| Q2 2020 | $27,000 | -12.9% | 650 | 0.0% | 0.02% | -15.0% |
| Q4 2019 | $31,000 | – | 650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |